These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 16412214)

  • 1. CD30+ lymphoproliferative disorders: histopathology, differential diagnosis, new variants, and simulators.
    Kempf W
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():58-70. PubMed ID: 16412214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
    Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
    Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathobiology of CD30+ cutaneous T-cell lymphomas.
    Kadin ME
    J Cutan Pathol; 2006 Feb; 33 Suppl 1():10-7. PubMed ID: 16412208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic evaluation of phenotypic markers TRAF1, MUM1, BCL2 and CD15 in cutaneous CD30-positive lymphoproliferative disorders.
    Benner MF; Jansen PM; Meijer CJ; Willemze R
    Br J Dermatol; 2009 Jul; 161(1):121-7. PubMed ID: 19416236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of longitudinal follow up and clinical pathological correlation in the diagnosis CD30-positive skin infiltrates.
    De Souza A; Carter JB; Harris NL; Ferry JA; Duncan LM
    J Cutan Pathol; 2015 Jul; 42(7):452-8. PubMed ID: 25931140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders.
    Greisser J; Palmedo G; Sander C; Kutzner H; Kazakov DV; Roos M; Burg G; Kempf W
    J Cutan Pathol; 2006 Nov; 33(11):711-5. PubMed ID: 17083688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous CD30+ lymphoproliferative disorder--a 10-year follow-up. A case report and differential diagnosis.
    Szpor J; Dyduch G; Gałazka K; Bahyrycz J; Stój A; Tomaszewska R
    Pol J Pathol; 2009; 60(1):43-8. PubMed ID: 19670703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large CD30-positive cells in benign, atypical lymphoid infiltrates of the skin.
    Werner B; Massone C; Kerl H; Cerroni L
    J Cutan Pathol; 2008 Dec; 35(12):1100-7. PubMed ID: 18616762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders.
    Kempf W
    Semin Diagn Pathol; 2017 Jan; 34(1):22-35. PubMed ID: 27993440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases.
    Kikuchi A; Nishikawa T
    Arch Dermatol; 1997 Jul; 133(7):829-33. PubMed ID: 9236520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of primary cutaneous large cell lymphomas.
    Willemze R; Beljaards RC; Rijlaarsdam U
    Dermatol Clin; 1994 Apr; 12(2):361-73. PubMed ID: 8045048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis in CD30-positive lymphoproliferative disorders of the skin.
    Greisser J; Doebbeling U; Roos M; Mueller B; Schmid M; Burg G; Kadin ME; Kempf W
    Exp Dermatol; 2005 May; 14(5):380-5. PubMed ID: 15854132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CD30-positive T-cell lymphoproliferative disorder of the oral mucosa--an indolent lesion: report of 4 cases.
    Agarwal M; Shenjere P; Blewitt RW; Hall G; Sloan P; Pigadas N; Banerjee SS
    Int J Surg Pathol; 2008 Jul; 16(3):286-90. PubMed ID: 18387994
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
    Paulli M; Berti E
    Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD30+ lymphoproliferative disorders of the skin: still an open question.
    Alaibac M; Zarian H; Russo I; Peserico A
    G Ital Dermatol Venereol; 2012 Dec; 147(6):545-52. PubMed ID: 23149700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXP3 positive regulatory T-cells in cutaneous and systemic CD30 positive T-cell lymphoproliferations.
    Gjerdrum LM; Woetmann A; Odum N; Hother C; Henrik-Nielsen R; Gniadecki R; Ralfkiaer E
    Eur J Haematol; 2008 Jun; 80(6):483-9. PubMed ID: 18331599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Jun expression and activation are restricted to CD30+ lymphoproliferative disorders.
    Drakos E; Leventaki V; Schlette EJ; Jones D; Lin P; Medeiros LJ; Rassidakis GZ
    Am J Surg Pathol; 2007 Mar; 31(3):447-53. PubMed ID: 17325487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD30-Positive Lymphoproliferative Disorders.
    Nikolaenko L; Zain J; Rosen ST; Querfeld C
    Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of CD30+ nasal natural killer/T-cell lymphoma.
    Ferenczi K; Summers P; Aubert P; Cooper B; Meyerson H; Cooper KD; Honda K
    Am J Dermatopathol; 2008 Dec; 30(6):567-71. PubMed ID: 19033930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.